Journal article icon

Journal article

Prevalence of low‐level viremia and its association with virological failure among adolescents living with HIV in Eastern Cape, South Africa

Abstract:
Objectives: Low‐level viremia (LLV) has been associated with an increased risk of virological failure among adults on antiretroviral therapy (ART). However, evidence on the clinical implications of LLV among adolescents living with HIV remains limited. This study aimed to assess the prevalence and predictors of LLV and to determine the association between LLV and subsequent virological failure. Methods: We analysed data from an integrated prospective cohort of adolescents living with HIV linked to the National Institute for Communicable Diseases (NICD) data warehouse in South Africa. Using routine viral load data from 2015 to 2021, we estimated the prevalence of LLV at the first test. We then used mixed‐effects logistic regression to identify socio‐demographic factors associated with LLV. Among adolescents with at least three viral load measurements, we assessed the association between LLV and subsequent virological failure using a Cox proportional hazards model in RStudio. Results: Among 730 adolescents, the prevalence of LLV ranged between 10.4% and 20.1%. Older adolescents aged 15–19 years (aOR: 1.92; 95% CI: 1.44–2.55) and those ≥20 years (aOR: 1.69; 95% CI: 1.12–2.57) had significantly higher odds of LLV compared to those 10–14 years. Among 617 adolescents, 13.3% had LLV, of which 17.1% subsequently progressed to virological failure. Those experiencing LLV were associated with a four‐fold (aHR 4.91; 95% CI: 2.46–9.79) increased hazard of virological failure compared to suppressed adolescents. Conclusions: The prevalence of LLV among adolescents living with HIV on ART is high and LLV strongly predicts virological failure. Enhanced adherence support for adolescents with LLV is needed to minimize the risk of long‐term virological failure.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/hiv.70228

Authors

More by this author
Role:
Author
ORCID:
0009-0005-7255-3645
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
10.13039/501100001321
Grant:
138070
More from this funder
Funder identifier:
10.13039/100019180
Grant:
771468
More from this funder
Funder identifier:
10.13039/501100004789
Grant:
161/033
More from this funder
Funder identifier:
https://ror.org/01cwqze88
Grant:
K43TW011434
More from this funder
Funder identifier:
https://ror.org/006ss0h52
Grant:
OFIL‐20‐057


Publisher:
Wiley
Journal:
HIV Medicine More from this journal
Article number:
hiv.70228
Publication date:
2026-04-05
Acceptance date:
2026-03-10
DOI:
EISSN:
1468-1293
ISSN:
1464-2662


Language:
English
Keywords:
Pubs id:
2404788
Local pid:
pubs:2404788
Source identifiers:
3919410
Deposit date:
2026-04-05
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP